In summary, while early intervention may benefit selected high-risk individuals, the evidence for a consistent mortality benefit remains limited. For most truly asymptomatic, low-risk patients, a conservative watchful waiting strategy with structured follow-up remains… https://t.co/5R2V2PJ5yZ
